In terms of DFS, patients with increased E2F1 (p < 0.001), E2F2 (p < 0.001), E2F7 (p < 0.001), and E2F8 (p = 0.001) tumor expression have a poorer prognosis (Fig. 4, right panel). Here, E2F1 is linked to neoplasm.